• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Nucletron expands exec ranks

Article

Three new vice presidents have joined the executive ranks of brachytherapy provider Nucletron.

Nucletron expands exec ranks
Three new vice presidents have joined the executive ranks of brachytherapy provider Nucletron. As vice president of global marketing, Jan Boers will be responsible for worldwide marketing and communications, joining the firm after serving in roles at CSM Food, Heinz, and Sara Lee International. John Lapré takes over as Nucletron's vice president of research and development following his most recent stint as VP of research and development for CP Kelco. Bringing nearly 20 years of international experience in the pharmaceutical industry, Dr. Jonathan Briers leads the company’s newly created medical affairs department, having served in product management and medical affairs at Servier International, SmithKline Beecham and, most recently, at Pfizer.  Briers previously held appointments at the University of Manchester Medical School in the U.K. and clinical posts in Manchester and Liverpool. 

Related Videos
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Related Content
© 2024 MJH Life Sciences

All rights reserved.